In this webinar experts from the SMoldons Pharmaceuticals UK team will discuss the challenges drug companies face in keeping up with a fast-changing regulatory landscape when developing APIs from R&D to commercial, both for New Chemical Entities (NCEs) and APIs for the generic market.

Key Learning Objectives

• Understand the challenges posed by the current regulatory environment
• Learn how to address challenges in lifecycle management when developing and maintaining a drug substance
• Learn the benefits of collaboration with an experienced CDMO with an integrated service offering to reduce risks and timelines